Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-07ABEO3Power of Attorney for Keith A. GoldanMEDIUM
This filing details a Power of Attorney granted by Keith A. Goldan to Joseph W. Vazzano (Chief Financial Officer) and Brendan M. O'Malley (Chief Legal Officer) of Abeona Therapeutics Inc. The attorneys-in-fact are authorized to act on Mr. Goldan's behalf for all necessary actions related to SEC filings, including EDGAR...
Micro CapBiotechnology
2026-04-07CASI3CASI Pharmaceuticals Officer Stock Option Holdings ReportMEDIUM
This Form 3 filing reports the initial beneficial ownership of CASI Pharmaceuticals, Inc. (CASIF) securities by Hai Huang, the company's Global Chief Commercial Officer. The filing details Huang's stock option holdings totaling 270,000 ordinary shares across multiple option grants with different exercise prices and ves...
Nano CapBiotechnology
2026-04-07IMMP3IMMUTEP Director Peter Meyers Reports 4.05M Shares and Performance Rights Holdings
This SEC Form 3 filing reports the initial statement of beneficial ownership by Peter Andrew Meyers, a director of IMMUTEP Ltd. The filing discloses Meyers' holdings of 4,052,173 ordinary shares in the company. Additionally, the filing reveals four separate grants of performance rights (rights to receive ordinary share...
Nano CapBiotechnology